Search by Drug Name or NDC
NDC 60505-6180-05 Glycopyrrolate 0.2 mg/mL Details
Glycopyrrolate 0.2 mg/mL
Glycopyrrolate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 60505-6180 |
|---|---|
| Product ID | 60505-6180_7ce03303-804b-88ff-f5dc-20043e2a9378 |
| Associated GPIs | 49102030002012 |
| GCN Sequence Number | 004886 |
| GCN Sequence Number Description | glycopyrrolate VIAL 0.2 MG/ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 19121 |
| HICL Sequence Number | 002028 |
| HICL Sequence Number Description | GLYCOPYRROLATE |
| Brand/Generic | Generic |
| Proprietary Name | Glycopyrrolate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210246 |
| Listing Certified Through | n/a |
Package
NDC 60505-6180-05 (60505618005)
| NDC Package Code | 60505-6180-5 |
|---|---|
| Billing NDC | 60505618005 |
| Package | 25 VIAL in 1 CARTON (60505-6180-5) / 2 mL in 1 VIAL |
| Marketing Start Date | 2020-06-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |